SciELO - Scientific Electronic Library Online

vol.37 issue3A review on autosomal dominant tubulointerstitial kidney diseaseRecommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Nefrología (Madrid)

On-line version ISSN 1989-2284Print version ISSN 0211-6995


BELMAR VEGA, Lara et al. New oral anticoagulants in patients with chronic kidney disease. Nefrología (Madr.) [online]. 2017, vol.37, n.3, pp.244-252. ISSN 1989-2284.

Patients with chronic kidney disease (CKD) develop bleeding and thrombotic tendencies, so the indication of anticoagulation at the onset of atrial fibrillation (AF) is complex. AF is the most common chronic cardiac arrhythmia, and thromboembolism and ischemic stroke in particular are major complications. In recent years, new oral anticoagulant drugs have been developed, and they have shown superiority over the classical AVK in preventing stroke, systemic embolism and bleeding risk, constituting an effective alternative to those resources.

Keywords : Oral anticoagulants; Atrial fibrillation; Chronic kidney disease.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )